Diabetic diseases have long been classified as either type 1 or type 2, but the new research conducted in Scandinavia now indicates that such classification is over-simplistic. Published in The Lancet ...
GLP-1 drugs like Ozempic and Mounjaro have significant health benefits for type 1 diabetes, including weight loss, despite ...
The European Commission has approved French pharma major Sanofi’s Teizeild (teplizumab) to delay the onset of stage 3 type 1 ...